120 related articles for article (PubMed ID: 26057517)
1. Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
Vassallo C; Carugno A; Derlino F; Ciocca O; Brazzelli V; Borroni G
Cutis; 2015 May; 95(5):E28-34. PubMed ID: 26057517
[TBL] [Abstract][Full Text] [Related]
2. [Intralesional injection of vinblastine in treatment of laryngeal Kaposi sarcoma associated with AIDS].
Gras R; Moulin G; Giovanni A; Chagnaud C; Triglia JM; Zanaret M
Ann Otolaryngol Chir Cervicofac; 1999 Oct; 116(5):291-4. PubMed ID: 10572593
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
Smith KJ; Skelton HG; Turiansky G; Wagner KF
J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):239-42. PubMed ID: 9039176
[TBL] [Abstract][Full Text] [Related]
4. Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patients.
Brambilla L; Bellinvia M; Tourlaki A; Scoppio B; Gaiani F; Boneschi V
Br J Dermatol; 2010 Apr; 162(4):854-9. PubMed ID: 19995366
[TBL] [Abstract][Full Text] [Related]
5. A juvenile case of classic Kaposi's sarcoma.
Erdem T; Atasoy M; Akdeniz N; Parlak M; Ozdemir S
Acta Derm Venereol; 1999 Nov; 79(6):492-3. PubMed ID: 10598779
[No Abstract] [Full Text] [Related]
6. Chemotherapy of disseminated cutaneous classic Kaposi's sarcoma with vinblastine.
Turk HM; Buyukberber S; Camci C; Inaloz HS; Sari I; Kirtak N; Uner A
J Dermatol; 2002 Oct; 29(10):657-60. PubMed ID: 12432999
[TBL] [Abstract][Full Text] [Related]
7. Intralesional vinblastine injections for the treatment of oral Kaposi's sarcoma: report of 10 patients with 2-year follow-up.
McCormick SU
J Oral Maxillofac Surg; 1996 May; 54(5):583-7; discussion 588-9. PubMed ID: 8632242
[TBL] [Abstract][Full Text] [Related]
8. Treatment of oral Kaposi sarcoma with intralesional vinblastine.
Epstein JB
Cancer; 1993 Mar; 71(5):1722-5. PubMed ID: 8448735
[TBL] [Abstract][Full Text] [Related]
9. Role of intralesional vinblastine administration in treatment of intraoral Kaposi's sarcoma in AIDS.
Flaitz CM; Nichols CM; Hicks MJ
Eur J Cancer B Oral Oncol; 1995 Jul; 31B(4):280-5. PubMed ID: 7492927
[TBL] [Abstract][Full Text] [Related]
10. Intralesional vinblastine vs. 3% sodium tetradecyl sulfate for the treatment of oral Kaposi's sarcoma. A double blind, randomized clinical trial.
Ramírez-Amador V; Esquivel-Pedraza L; Lozada-Nur F; De la Rosa-García E; Volkow-Fernández P; Súchil-Bernal L; Mohar A
Oral Oncol; 2002 Jul; 38(5):460-7. PubMed ID: 12110340
[TBL] [Abstract][Full Text] [Related]
11. Classic Kaposi sarcoma presenting as rapidly growing nodules.
Lim TW; Lee MH; Park JG; Cho BK
Cutis; 2001 Jul; 68(1):50-2. PubMed ID: 11480148
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine.
Nazzaro G; Genovese G; Tourlaki A; Passoni E; Berti E; Brambilla L
Skin Res Technol; 2019 Mar; 25(2):200-203. PubMed ID: 30311687
[TBL] [Abstract][Full Text] [Related]
13. Vinorelbine therapy in classic Kaposi's sarcoma: a retrospective study of 20 patients.
Brambilla L; Recalcati S; Tourlaki A
Eur J Dermatol; 2015; 25(6):535-8. PubMed ID: 26552718
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of classic Kaposi's sarcoma growth after intralesional injections of desferrioxamine.
Simonart T; Boelaert JR; Van Vooren JP
Dermatology; 2002; 204(4):290-2. PubMed ID: 12077524
[TBL] [Abstract][Full Text] [Related]
15. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection.
Boudreaux AA; Smith LL; Cosby CD; Bason MM; Tappero JW; Berger TG
J Am Acad Dermatol; 1993 Jan; 28(1):61-5. PubMed ID: 8381146
[TBL] [Abstract][Full Text] [Related]
16. Intralesional vinblastine for treating AIDS-associated Kaposi's sarcoma of the oropharynx and larynx.
Friedman M; Venkatesan TK; Caldarelli DD
Ann Otol Rhinol Laryngol; 1996 Apr; 105(4):272-4. PubMed ID: 8604887
[TBL] [Abstract][Full Text] [Related]
17. Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine.
Epstein JB; Lozada-Nur F; McLeod WA; Spinelli J
Cancer; 1989 Dec; 64(12):2424-30. PubMed ID: 2819653
[TBL] [Abstract][Full Text] [Related]
18. [Off-label use of vincristine for intralesional treatment of isolated papules in Kaposi's sarcoma: Dermatologic experience with 10 patients].
Peduto T; Fabbrocini G; Delfino M; Nappa P; Guarino M; Cillo F
Ann Dermatol Venereol; 2020 Feb; 147(2):140-143. PubMed ID: 31810583
[No Abstract] [Full Text] [Related]
19. [Evaluation of the treatment of Kaposi's sarcoma with vinblastine in Togo: a study of 23 cases].
Saka B; Kombaté K; Mouhari-Toure A; Akakpo S; Balaka A; Pitché P; Tchangaï-Walla K
Bull Soc Pathol Exot; 2011 Dec; 104(5):339-41. PubMed ID: 21359830
[TBL] [Abstract][Full Text] [Related]
20. Iontophoresis of vinblastine into normal skin and for treatment of Kaposi's sarcoma in human immunodeficiency virus-positive patients. The Military Medical Consortium for Applied Retroviral Research.
Smith KJ; Konzelman JL; Lombardo FA; Skelton HG; Holland TT; Yeager J; Wagner KF; Oster CN; Chung R
Arch Dermatol; 1992 Oct; 128(10):1365-70. PubMed ID: 1417025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
